Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine.
- Mechanical Engineering - Aug 20 The power of salt
- Microtechnics - Aug 19 Why this U of’T biotech entrepreneur made MIT’s Innovators Under 35 list
- Pedagogy - Aug 19 How parents juggle work hours may influence kids' weight
- Mechanical Engineering - Aug 19 Wong named one of world's top Innovators Under 35 by MIT Technology Review
- Medicine - Aug 19 Mother whose young daughter died from ovarian cancer raises money for UCLA cancer research
- Social Sciences - Aug 19 Hungry workers feel more entitled, research suggests
- Event - Aug 19 Poetry's evolutionary niche at Cornell Plantations
- Medicine - Aug 19 Heart disease and strokes have dropped in the U.S. in last decade
- Administration - Aug 19 Congressional staffers learn about cybersecurity at Stanford boot camp
- Environmental Sciences - Aug 19 A gentle reminder – and guidelines – from Stanford Recycling
- Literature - Aug 19 Stanford scholar sees failure as key element of success for famous American authors
Prostate cancer treatment overused in some older patients
"Treatment can do more harm than good in some instances," said senior author on the study Cary Gross , associate professor of internal medicine at Yale School of Medicine. "Among men who are older and have less aggressive forms of prostate cancer, their cancer is unlikely to progress or cause them harm in their remaining years."
Gross and his team analyzed nine years of Medicare data and found that over the past decade, there has been a trend towards higher use of curative treatment for prostate cancer among men with certain types of tumors and a short life expectancy. The study included 39,270 patients between the ages of 67 and older.
These results suggest that cancer treatment was increasingly aggressive in patients who had the lowest likelihood of seeing clinical benefits, Gross said, noting that while not treating potentially fatal cancer can reflect poor-quality care, aggressively managing disease that is unlikely to progress puts patients at risk for complications and increases costs without medical benefits.
"We found that the percentage of men who received treatment for their prostate cancer treatments increased over time from 61.2% to 67.6% from 1998 through 2007," said Gross, who is a member of Yale Cancer Center. "However, we were surprised to find that the biggest increase was among men with moderate-risk prostate cancer who had the shortest life expectancy. On the other hand, cancer treatment decreased among men with low-risk tumors and longer life expectancy."
Treating patients with shorter life expectancy may add costs or complications without contributing to quality of life, he said. The National Comprehensive Cancer Network practice guidelines in oncology recommend actively monitoring patients as an alternative to medication for patients with less aggressive tumor types and shorter life expectancies.
Gross said that the use of cancer therapies should be guided by clinical evidence and patient preferences. "Future work should explore how better to incorporate both cancer characteristics and patient life expectancy into decision making," said Gross.
Other authors on the study included Ann c. Raldow, M.D., Carolyn J. Presley, M.D., James B. Yu, M.D., Richa Sharma, Pamela R. Soulos, Jessica B. Long, and Danil V. Makarov, M.D.
The National Cancer Institute and the James G. Hirsch Medical Student Research Fellowship funded the study.
Citation: Arch. Inter. Med. Vol. 172, No. 4 (February 27, 2012)
Last job offers
- Medicine - 20.8
- Business - 20.8
Assistant or Associate Professor
- Medicine - 20.8
Clinical Assistant Professor / JACSW
- Chemistry - 20.8
Assistant Professor---Bio-Organic / Chemical Biology- Chemistry
- Chemistry - 20.8
Assistant Professor - Physical-- Chemistry
- Life Sciences - 19.8
Microbiology - Assistant Professor (AA7671)
- Literature - 19.8
- Philosophy - 19.8
Assistant / Associate Professor